The inhibition of GLI1 following chemotherapy may serve as a novel strategy to ensure the crucial killing effect of chemotherapy on tumour cells and inhibit the chemotherapy-exacerbated metastasis in ovarian cancer treatment. Here, GLI1 is linked to neoplasm.